NLRP3 and cardiac hypertrophy: Studies have shown that in a TAC-induced myocardial hypertrophy model, the NLRP3 inflammasome can be alleviated by regulating the NF- κB signaling pathway to alleviate myocardial hypertrophy (Ren et al., 2021).